IE40906L - Antibiotic mixture - Google Patents
Antibiotic mixtureInfo
- Publication number
- IE40906L IE40906L IE750745A IE74575A IE40906L IE 40906 L IE40906 L IE 40906L IE 750745 A IE750745 A IE 750745A IE 74575 A IE74575 A IE 74575A IE 40906 L IE40906 L IE 40906L
- Authority
- IE
- Ireland
- Prior art keywords
- ethanol
- antibiotic
- chloroform
- absorption
- soluble
- Prior art date
Links
- 230000003115 biocidal effect Effects 0.000 title abstract 11
- 239000000203 mixture Substances 0.000 title abstract 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 20
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 abstract 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 abstract 9
- 238000010521 absorption reaction Methods 0.000 abstract 8
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 abstract 6
- 229910052799 carbon Inorganic materials 0.000 abstract 5
- 229910052757 nitrogen Inorganic materials 0.000 abstract 5
- 238000010438 heat treatment Methods 0.000 abstract 4
- 230000003287 optical effect Effects 0.000 abstract 4
- 239000003242 anti bacterial agent Substances 0.000 abstract 3
- 229940088710 antibiotic agent Drugs 0.000 abstract 3
- 238000000354 decomposition reaction Methods 0.000 abstract 3
- 238000001228 spectrum Methods 0.000 abstract 3
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 abstract 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 229940125807 compound 37 Drugs 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 abstract 1
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 abstract 1
- 241000219205 Actinoplanes auranticolor Species 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 229940125878 compound 36 Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- ZYBWTEQKHIADDQ-UHFFFAOYSA-N ethanol;methanol Chemical compound OC.CCO ZYBWTEQKHIADDQ-UHFFFAOYSA-N 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
- C07G11/00—Antibiotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fodder In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Feed For Specific Animals (AREA)
Abstract
1479063 Antibiotics PFIZER Inc 16 April 1975 [16 April 1974 17 Jan 1975] 15748/75 Heading C2A A synergistic antibiotic mixture comprises compounds 35, 763, 36, 926, 37, 277 and 37, 932 and miscellaneous lesser antibiotic components produced by cultivating Actinoplanes auranticolor ATCC 31011 under submerged aerobic conditions in an aqueous nutrient medium containing an assimilable source of carbon and nitrogen until substantial antibiotic activity is obtained and separating the antibiotic mixture therefrom. Antibiotic compound 37, 277 is in crystalline form and has an optical rotation of [α] D <SP>25‹</SP>= + 11‹ at a concentration of 1% in ethanol, absorption maxima in ethanol in the ultra-violet region at 225, 274, 282, 303 and 355 mÁ with E<SP>1%</SP> 1cm values of 309À3, 36.67, 45.01, 70 and 20, an average composition by weight of 60.91% C, 5.98% H, 10.45% N and 22.66% O, when dissolved in chloroform exhibits the absorption characteristics indicated in Fig. 1 (not shown), on heating decomposes between 145‹ and 150‹ C., is insoluble in diethyl ether, Lexane, treptane and water, slightly soluble in acetone and leuzene, and readily soluble in methanol ethanol, chloroform and methylene chloride. Antibiotic compound 36, 926 has an average composition by weight of 57.89% C, 6.78% H, 8.04% N and 27.29% O, a molecular formula C 26 H 35 N 3 0 7 , an optical rotation of [α] D <SP>25‹</SP>=-130‹ at a concentration of 1% in ethanol, absorption maximum in ethanol in the ultra-violet region of the spectrum at 214 mÁ. with E<SP>1%</SP> 1cm of 723À8, 8 when spectrum at 214 mÁ with E<SP>1%</SP> 1cm of 723À8, when pelleted on KBr exhibits the absorption characteristics indicated in Fig. 2 (not shown), and on heating, decomposition commences at 100‹ C., is soluble in ethanol, methanol, chloroform and methylene chloride and insoluble in diethyl ether, hexane and heptane. Antibiotic compound 35, 763 has the molecular formula C 26 H 27 N 3 O 7 , an optical rotation of [α] D <SP>25‹</SP>=-114‹ at a concentration of 1% in ethanol, absorption maximum in ethanol in the ultra violet region at 218 mÁ with E<SP>1%</SP> 1cm of 668.9, when pelleted in KBr exhibits the absorption characteristic indicated in Fig. 3 (not shown), is soluble in methanol, ethanol, chloroform and methylene chloride, insouble in diethyl ether, heptane and hexane, on heating decomposition commences at 100‹ C., has a M.Wt of 503 and an average composition by weight of 61À29% C, 6À73% H, 8À83% N and 23À15% O. Antibiotic compound 37, 932 is in crystalline form and has an optical rotation of [α] D <SP>25‹</SP> = + 5.0‹ at a concentration of 0.25% in chloroform, absorption maxima in ethanol in the ultra-violet region of the spectrum at 226, 276, 283, 305 and 355 mÁ with E<SP>1%</SP> 1cm values of 304.4, 36.8, 43.49, 70.25 and 20.07, an average composition by weight of 59.41% C, 6À01% H, 10À66% N and 23.92% O when pelleted in KBr exhibits the absorption characteristics indicated on Fig. 4 (not shown) and is soluble in methanol, ethanol, chloroform and methylene chloride, is insoluble in diethyl ether, hexane, heptane and water and on heating decomposition commences at 185‹ C. The antibiotic mixture or one or more of the antibiotics may be admixed with a pharmaceutically acceptable carrier to form a pharmaceutical composition. The antibiotic mixture or one or more of the antibiotics may be incorporated in an animal feed composition.
[GB1479063A]
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46129874A | 1974-04-16 | 1974-04-16 | |
| US54180075A | 1975-01-17 | 1975-01-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE40906L true IE40906L (en) | 1975-10-16 |
| IE40906B1 IE40906B1 (en) | 1979-09-12 |
Family
ID=27039975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE745/75A IE40906B1 (en) | 1974-04-16 | 1975-04-03 | Improvements in or relating to antibiotics |
Country Status (26)
| Country | Link |
|---|---|
| JP (2) | JPS548760B2 (en) |
| AR (1) | AR207359A1 (en) |
| AU (1) | AU475745B2 (en) |
| BG (1) | BG28268A3 (en) |
| CA (1) | CA1045568A (en) |
| CH (1) | CH606423A5 (en) |
| CS (1) | CS196262B2 (en) |
| DD (2) | DD122778A5 (en) |
| DE (1) | DE2516020A1 (en) |
| DK (1) | DK138758B (en) |
| ES (1) | ES436615A1 (en) |
| FI (1) | FI54326C (en) |
| FR (1) | FR2287915A1 (en) |
| GB (1) | GB1479063A (en) |
| HU (1) | HU171026B (en) |
| IE (1) | IE40906B1 (en) |
| IL (1) | IL47004A (en) |
| IT (1) | IT1053258B (en) |
| LU (1) | LU72292A1 (en) |
| NL (1) | NL159436B (en) |
| NO (1) | NO143107C (en) |
| PH (4) | PH14603A (en) |
| RO (1) | RO68835A (en) |
| SE (1) | SE423246B (en) |
| SU (1) | SU552907A3 (en) |
| YU (1) | YU90275A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6147714A (en) * | 1984-08-14 | 1986-03-08 | Agency Of Ind Science & Technol | Graft polymerization process |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL42685A (en) * | 1972-07-31 | 1976-01-30 | Lilly Co Eli | Antibiotic a-2315 and process for preparation thereof |
-
1975
- 1975-01-01 AR AR258391A patent/AR207359A1/en active
- 1975-04-01 SE SE7503724A patent/SE423246B/en not_active IP Right Cessation
- 1975-04-03 IL IL47004A patent/IL47004A/en unknown
- 1975-04-03 IE IE745/75A patent/IE40906B1/en unknown
- 1975-04-03 NO NO751149A patent/NO143107C/en unknown
- 1975-04-04 AU AU79833/75A patent/AU475745B2/en not_active Expired
- 1975-04-07 PH PH17024A patent/PH14603A/en unknown
- 1975-04-09 YU YU00902/75A patent/YU90275A/en unknown
- 1975-04-12 DE DE19752516020 patent/DE2516020A1/en active Pending
- 1975-04-12 BG BG029639A patent/BG28268A3/en unknown
- 1975-04-15 CA CA224,595A patent/CA1045568A/en not_active Expired
- 1975-04-15 ES ES436615A patent/ES436615A1/en not_active Expired
- 1975-04-15 DD DD191038A patent/DD122778A5/xx unknown
- 1975-04-15 DK DK161075AA patent/DK138758B/en not_active IP Right Cessation
- 1975-04-15 NL NL7504453.A patent/NL159436B/en not_active IP Right Cessation
- 1975-04-15 HU HU75PI00000464A patent/HU171026B/en not_active IP Right Cessation
- 1975-04-15 IT IT49091/75A patent/IT1053258B/en active
- 1975-04-15 SU SU2137352A patent/SU552907A3/en active
- 1975-04-15 FI FI751107A patent/FI54326C/en not_active IP Right Cessation
- 1975-04-15 DD DD185452A patent/DD118119A5/xx unknown
- 1975-04-16 JP JP4629375A patent/JPS548760B2/ja not_active Expired
- 1975-04-16 FR FR7511848A patent/FR2287915A1/en active Granted
- 1975-04-16 RO RO7582003A patent/RO68835A/en unknown
- 1975-04-16 CS CS752641A patent/CS196262B2/en unknown
- 1975-04-16 GB GB15748/75A patent/GB1479063A/en not_active Expired
- 1975-04-16 CH CH487675A patent/CH606423A5/xx not_active IP Right Cessation
- 1975-04-16 LU LU72292A patent/LU72292A1/xx unknown
- 1975-05-30 JP JP50065248A patent/JPS5831919B2/en not_active Expired
-
1977
- 1977-11-24 PH PH20484A patent/PH15618A/en unknown
- 1977-11-24 PH PH20482A patent/PH13963A/en unknown
- 1977-11-24 PH PH20483A patent/PH13383A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1436447A (en) | Rapamycin and process of preparation | |
| GB985598A (en) | Improvements in or relating to antibiotics and their preparation | |
| KR900008049A (en) | BU-3608 Serine Homolog of Antibiotic | |
| ES445965A1 (en) | Papulacandin derivatives and pharmaceutical compositions containing same | |
| GB1454735A (en) | Lincomycin production | |
| IE40906L (en) | Antibiotic mixture | |
| GB1314657A (en) | Antibiotics | |
| GB1501144A (en) | Cyclic ether antibiotics | |
| GB1500965A (en) | Cyclic ether antibiotics | |
| GB1525977A (en) | Aminoglycoside antibiotic complex | |
| KR920009986A (en) | Dainemycin C Antineoplastic Antibiotics | |
| GB1225379A (en) | ||
| GB1159970A (en) | The Antibiotic Steffisburgensimycin | |
| GB1500847A (en) | Antibiotic a process for its preparation and its use as a medicament | |
| GB1345676A (en) | Antibiotic 1-4696 | |
| GB1504994A (en) | Naphthyridinomycin antibiotics and preparation thereof | |
| GB1500846A (en) | Antibiotic a process for its preparation and its use as a medicament | |
| GB1381180A (en) | Antibiotic | |
| GB1440288A (en) | Antibiotic and process for producing the same | |
| IE45349L (en) | Antibiotic bl580 delta | |
| GB1439668A (en) | Antibiotic bm123 and production thereof | |
| GB1438785A (en) | Antibiotics and a process for the preparation thereof | |
| GB1290475A (en) | ||
| GB1127224A (en) | New antibiotic a3823 and method of making same | |
| KR830002034A (en) | Istamycin and its preparation |